Outpatient drug safety: new steps in an old direction

Pharmacoepidemiology and Drug Safety
Daniel S Budnitz, Peter M Layde

Abstract

Iatrogenic injury from adverse drug events (ADEs) is a common and often preventable problem in modern medical practice. Attention to this problem has focused on the inpatient hospital setting and healthcare professionals. However, most medication is prescribed and used outside of hospitals and is managed by patients or lay caregivers in homes or workplaces. To address the public health problem of outpatient drug safety, interventions to prevent adverse events must recognize the central role of the patient in medication management and environmental factors specific to the outpatient setting. Lessons and techniques from the field of injury prevention should guide the development and implementation of safety interventions. First, Haddon's phase-factor matrix can be used to help conceptualize outpatient drug safety interventions. Second, interventions to improve outpatient drug safety should be patient-centered and extend beyond patient education to include engineering innovations and enforcement strategies. Third, the sustainability of active versus passive interventions should be considered when choosing safety interventions.

References

Jan 1, 1991·International Journal of Technology Assessment in Health Care·T L Chorba
Feb 1, 1987·Infection Control : IC·B S RibnerL A Linden
Feb 1, 1987·Infection Control : IC·K KrasinskiR S Holzman
Dec 6, 1995·JAMA : the Journal of the American Medical Association·M V WilliamsJ R Nurss
Apr 29, 1998·JAMA : the Journal of the American Medical Association·J LazarouP N Corey
Jan 8, 1999·The Milbank Quarterly·M R Chassin
May 4, 2000·American Journal of Preventive Medicine·C W RunyanC Zwerling
Feb 28, 2002·Annals of Emergency Medicine·John W HafnerKay A Bucheit
Apr 19, 2002·JAMA : the Journal of the American Medical Association·Peter M LaydeLeslie A Maas
Mar 8, 2003·JAMA : the Journal of the American Medical Association·Jerry H GurwitzDavid W Bates
Mar 28, 2003·The Journal of Hospital Infection·J C Trim, T S J Elliott
Apr 18, 2003·The New England Journal of Medicine·Tejal K GandhiDavid W Bates
Apr 18, 2003·The New England Journal of Medicine·William M Tierney
Jan 26, 2005·Archives of Internal Medicine·Saul N WeingartDavid W Bates
Jan 27, 2005·Annals of Emergency Medicine·Daniel S BudnitzJoseph L Annest
May 25, 2005·Archives of Internal Medicine·Jonathan R NebekerJohn F Hurdle
Jun 7, 2005·Journal of the American Geriatrics Society·Joshua P MetlaySean Hennessy
Sep 1, 2005·Joint Commission Journal on Quality and Patient Safety·Chunliu ZhanDaniel Stryer

❮ Previous
Next ❯

Citations

Aug 28, 2012·International Journal of Clinical Pharmacy·Lucien RouletFrançoise Ballereau
Oct 3, 2009·The New England Journal of Medicine·Daniel S BudnitzDebra Birnkrant
Dec 17, 2008·The Journal of Dermatological Treatment·Rajesh BalkrishnanSteven R Feldman
Mar 22, 2016·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Anthony Johnson, Rachel Meyers
Aug 12, 2009·American Journal of Preventive Medicine·Sarah F SchillieDaniel S Budnitz
Apr 29, 2008·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Daniel S Budnitz
Mar 22, 2012·Rehabilitation Nursing : the Official Journal of the Association of Rehabilitation Nurses·Carolee Polek, Thomas Hardie
Dec 17, 2009·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Ethan CumblerJean Kutner
Jan 22, 2008·The Journal of Pediatrics·Yogini Hariprasad JaniIan Chi Kei Wong
Apr 22, 2016·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Meredith Y Smith, Isma Benattia
Nov 6, 2018·Health Affairs·Anjana E SharmaUrmimala Sarkar
Nov 21, 2009·Journal of Patient Safety·Asta V Sorensen, Shulamit L Bernard
Mar 14, 2021·British Journal of Clinical Pharmacology·Kathryn HainesPhilip A Routledge
Jun 13, 2021·Journal of the American Medical Informatics Association : JAMIA·Matthew A WillisTiffany C Veinot
Nov 5, 2009·Pediatrics·Russell L RothmanCarole Lannon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.